In Phase A, individuals will receive unique doses and schedules of oral ABBV-744 tablet to discover Secure dosing routine. Supplemental members is going to be enrolled on the determined monotherapy dosign routine. In Section B, contributors will receive oral ruxolitinib and ABBV-744 is going to be presented as "add-on" therapy. https://abbv-744cancertreatmentcl13680.ambien-blog.com/38277185/5-easy-facts-about-abbv-744-combination-therapy-with-chemotherapy-described